Our top priority is always the health and safety of our patients, employees, and the communities we serve.
Part of that commitment is to help you get answers to the many questions you have about the coronavirus disease (COVID-19) and to make sure you know that you access to Covid19 IGM and IGG antibody testing.
Who should get tested?
The Centers for Disease Control and Prevention (CDC) recommends calling your doctor if you:
- Experience symptoms (fever, cough, shortness of breath)
- Have been in close contact with a person with COVID-19
- Have recently traveled from an area with a widespread outbreak
Don’t wait. Early detection means you can take precautions right away to limit the spread of the illness to those around you.
April 8, 2020: Interim Estimate of the US PPE Needs for COVID-19 (PDF)
March 29, 2020: National coronavirus response: A road map to reopening
Coronaviruses Fact Sheet (PDF)
Coronaviruses (CoV) are a family of RNA viruses that typically cause mild respiratory disease in humans. A novel coronavirus was identified in Wuhan, China, in December 2019.
US Travel Screening (PDF), as of January 22, 2020
The US Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security’s Customs and Border Protection (DHS/CBP) agency are implementing returning traveler screening for all travelers on direct or connecting flights from Wuhan, China.
COVID-19 Genetics (PDF)
A summary of findings from the latest phylogenetic research on COVID-19.
Financing for epidemic response activities (PDF)
There are several major sources of money that could be used to support outbreak response activities.
WHO’s Role During Health Emergencies (PDF)
As the health lead for the United Nations, the World Health Organization (WHO) has the primary responsibility to respond to natural disasters and disease outbreaks.
Diagnostic Testing for COVID-19 (PDF)
Diagnostic testing for the novel coronavirus COVID-19 is undertaken using 2 approaches: whole genome sequencing and real-time reverse transcriptase PCR (rRT-PCR).
Blame and Discrimination Attached to COVID-19—An FAQ for US Elected Leaders and Health Officials (PDF)
When fear of disease and fear of others collide
Ventilator Stockpiling and Availability in the US (PDF)
Mechanical ventilation is a vital component of critical services for patients exhibiting severe acute respiratory failure.
Serology testing for COVID-19 (PDF)
Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen.
Federal Public Health Response Capacities (PDF)
The US emergency preparedness, response, and recovery enterprise consists of a broad range of stakeholders and assets operating at federal, state, and local levels.
Review of Mobile Application Technology to Enhance Contact Tracing Capacity for COVID-19 (PDF)
Contact tracing is a mainstay of a robust public health response. The purpose of contact tracing is to identify potentially exposed (and therefore potentially infected) individuals so that they can be quarantined before they develop symptoms, thus preventing further transmission in the community.
Vaccines in Development to Target COVID-19 Disease (DF)
Since its emergence in December 2019 in Wuhan, China, the SARS-CoV-2 virus has caused more than 1.3 million cases and nearly 75,000 deaths globally as of April 06, 2020.1 Currently, no vaccine or proven treatment exists for this virus or any coronavirus.
Comparison of National RT-PCR Primers, Probes, and Protocols for SARS-CoV-2 Diagnostics (PDF)
This fact sheet provides a detailed comparison of several RT-PCR tests developed by various countries. Our review is limited to those listed in the World Health Organization (WHO) resource of in-house–developed molecular assays that have been used as the national test of choice in many countries and in regional reference laboratories.
Serology-based tests for COVID-19
This resource serves to provide up to date information on serology tests that are in development or available for use.